These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

701 related articles for article (PubMed ID: 215920)

  • 41. Genotype-dependent sensitivity to morphine: dopamine involvement in morphine-induced running in the mouse.
    Trabucchi M; Spano PF; Racagni G; Oliverio A
    Brain Res; 1976 Sep; 114(3):536-40. PubMed ID: 182326
    [No Abstract]   [Full Text] [Related]  

  • 42. Regulation of dopamine receptor sensitivity by an endogenous protein activator or adenylate cyclase.
    Costa E; Gnegy MG; Uzunov P
    Naunyn Schmiedebergs Arch Pharmacol; 1977; 297 Suppl 1():S47-8. PubMed ID: 193053
    [No Abstract]   [Full Text] [Related]  

  • 43. Aporphines. 39. Synthesis, dopamine receptor binding, and pharmacological activity of (R)-(-)- and (S)-(+)-2-hydroxyapomorphine.
    Neumeyer JL; Arana GW; Ram VJ; Kula NS; Baldessarini RJ
    J Med Chem; 1982 Aug; 25(8):990-2. PubMed ID: 7120288
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Posterior pituitary adenylate cyclase: stimulation by dopamine and other agents.
    Ahn HS; Feldman SC; Makman MH
    Brain Res; 1979 Apr; 166(2):422-5. PubMed ID: 218697
    [No Abstract]   [Full Text] [Related]  

  • 45. Three classes of dopamine receptor (D-2, D-3, D-4) identified by binding studies with 3H-apomorphine and 3H-domperidone.
    Sokoloff P; Martres MP; Schwartz JC
    Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(2):89-102. PubMed ID: 7207647
    [No Abstract]   [Full Text] [Related]  

  • 46. Localization of dopamine receptors in rat brain.
    Reisine TD; Nagy JI; Fibiger HC; Yamamura HI
    Brain Res; 1979 Jun; 169(1):209-14. PubMed ID: 455093
    [No Abstract]   [Full Text] [Related]  

  • 47. Dopamine-mimetic activity of ergot derivatives, as measured by the production of cyclic AMP in isolated retinae of the rabbit.
    Schorderet M
    Gerontology; 1978; 24 Suppl 1():86-93. PubMed ID: 201543
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Apparent dopamine D1 and D2 receptors in the weaver mutant mouse: receptor binding and coupling to adenylyl cyclase.
    Dewar KM; Paquet M; Sequeira A
    J Neural Transm (Vienna); 1999; 106(5-6):487-97. PubMed ID: 10443552
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chemical lesion and drug induced supersensitivity and subsensitivity of caudate dopamine receptors.
    Mishra RK; Wong YW; Varmuza SL; Tuff L
    Life Sci; 1978 Aug; 23(5):443-6. PubMed ID: 692267
    [No Abstract]   [Full Text] [Related]  

  • 50. The effects of nigrostriatal 6-hydroxydopamine lesions on dopamine D2 receptor mRNA and opioid systems.
    Mansour A; Meador-Woodruff JH; Camp DM; Robinson TE; Bunzow J; Van Tol H; Civelli O; Akil H; Watson SJ
    Prog Clin Biol Res; 1990; 328():227-30. PubMed ID: 2106148
    [No Abstract]   [Full Text] [Related]  

  • 51. On the cyclic nucleotides involvement in rat striatal function.
    Carenzi A; Govoni S; Spano PF; Trabucchi M
    Pharmacol Res Commun; 1976 Oct; 8(5):519-24. PubMed ID: 194261
    [No Abstract]   [Full Text] [Related]  

  • 52. Binding interactions of ergot alkaloids with monoaminergic receptors in the brain.
    Goldstein M; Lew JY; Hata F; Lieberman A
    Gerontology; 1978; 24 Suppl 1():76-85. PubMed ID: 22480
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Animal models of parkinsonism.
    Silbergeld EK; Calne DB
    Pharmacol Ther; 1981; 12(1):159-66. PubMed ID: 7271971
    [No Abstract]   [Full Text] [Related]  

  • 54. Acute and chronic amphetamine treatments modulate striatal dopamine receptor binding sites.
    Howlett DR; Nahorski SR
    Brain Res; 1979 Jan; 161(1):173-8. PubMed ID: 758968
    [No Abstract]   [Full Text] [Related]  

  • 55. Dopamine receptor supersensitivity and schizophrenia: a review.
    Langer DH; Brown GL; Docherty JP
    Schizophr Bull; 1981; 7(2):208-24. PubMed ID: 7025187
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of dopamine D-1 and D-2 receptors.
    Hyttel J; Arnt J
    Adv Exp Med Biol; 1986; 204():15-28. PubMed ID: 2878578
    [No Abstract]   [Full Text] [Related]  

  • 57. Dopamine inhibition of neurotensin-induced increase in Ca2+ influx into rat pituitary cells.
    Memo M; Carboni E; Trabucchi M; Carruba MO; Spano PF
    Brain Res; 1985 Nov; 347(2):253-7. PubMed ID: 2415214
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of the tuberoinfundibular and nigrostriatal systems. Evidence for different kinds of dopaminergic neurons in the brain.
    Annunziato L
    Neuroendocrinology; 1979; 29(1):66-76. PubMed ID: 471198
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of dopaminergic agonists and antagonists on [3H]apomorphine binding to striatal membranes: sulpiride lack of interactions with positive cooperative [3H]apomorphine binding.
    Fujita N; Saito K; Hirata A; Iwatsubo K; Noguchi Y; Yoshida H
    Brain Res; 1980 Oct; 199(2):335-42. PubMed ID: 7417787
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aging process affects a single class of dopamine receptors.
    Memo M; Lucchi L; Spano PF; Trabucchi M
    Brain Res; 1980 Dec; 202(2):488-92. PubMed ID: 7437912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.